Is Tenet Healthcare (THC) Stock Undervalued Right Now?

25.07.25 15:40 Uhr

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value investors use fundamental analysis and traditional valuation metrics to find stocks that they believe are being undervalued by the market at large.Luckily, Zacks has developed its own Style Scores system in an effort to find stocks with specific traits. Value investors will be interested in the system's "Value" category. Stocks with both "A" grades in the Value category and high Zacks Ranks are among the strongest value stocks on the market right now.One company value investors might notice is Tenet Healthcare (THC). THC is currently holding a Zacks Rank #1 (Strong Buy) and a Value grade of A. The stock is trading with a P/E ratio of 11.97, which compares to its industry's average of 11.99. Over the last 12 months, THC's Forward P/E has been as high as 16.94 and as low as 8.81, with a median of 12.56. Investors will also notice that THC has a PEG ratio of 1.17. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. THC's industry currently sports an average PEG of 1.23. Over the last 12 months, THC's PEG has been as high as 1.36 and as low as 0.55, with a median of 0.82.Finally, we should also recognize that THC has a P/CF ratio of 6.55. This metric takes into account a company's operating cash flow and can be used to find stocks that are undervalued based on their solid cash outlook. THC's P/CF compares to its industry's average P/CF of 6.85. THC's P/CF has been as high as 7.36 and as low as 2.83, with a median of 3.97, all within the past year.These figures are just a handful of the metrics value investors tend to look at, but they help show that Tenet Healthcare is likely being undervalued right now. Considering this, as well as the strength of its earnings outlook, THC feels like a great value stock at the moment.#1 Semiconductor Stock to Buy (Not NVDA)The incredible demand for data is fueling the market's next digital gold rush. As data centers continue to be built and constantly upgraded, the companies that provide the hardware for these behemoths will become the NVIDIAs of tomorrow.One under-the-radar chipmaker is uniquely positioned to take advantage of the next growth stage of this market. It specializes in semiconductor products that titans like NVIDIA don't build. It's just beginning to enter the spotlight, which is exactly where you want to be.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Tenet Healthcare Corporation (THC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Quelle: Zacks

Nachrichten zu Tenet Healthcare Corp.

Wer­bung

Analysen zu Tenet Healthcare Corp.

DatumRatingAnalyst
26.11.2012Tenet Healthcare neutralRobert W. Baird & Co. Incorporated
25.09.2012Tenet Healthcare neutralUBS AG
17.05.2012Tenet Healthcare overweightBarclays Capital
10.05.2012Tenet Healthcare overweightBarclays Capital
02.04.2012Tenet Healthcare overweightBarclays Capital
DatumRatingAnalyst
17.05.2012Tenet Healthcare overweightBarclays Capital
10.05.2012Tenet Healthcare overweightBarclays Capital
02.04.2012Tenet Healthcare overweightBarclays Capital
03.11.2011Tenet Healthcare overweightBarclays Capital
04.08.2011Tenet Healthcare overweightBarclays Capital
DatumRatingAnalyst
26.11.2012Tenet Healthcare neutralRobert W. Baird & Co. Incorporated
25.09.2012Tenet Healthcare neutralUBS AG
03.11.2011Tenet Healthcare sector performRBC Capital Markets
21.07.2010Tenet Healthcare neutralUBS AG
02.06.2010Tenet Healthcare DowngradeRobert W. Baird & Co. Incorporated
DatumRatingAnalyst
28.01.2009Tenet Healthcare underperformRBC Capital Markets
01.10.2008Tenet Healthcare DowngradeUBS AG
08.11.2007Tenet Healthcare underweightLehman Brothers Inc.
08.11.2007Tenet Healthcare underperformCowen and Company, LLC
11.09.2007Tenet Healthcare underweightLehman Brothers Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Tenet Healthcare Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen